Tci Wealth Advisors, Inc. Leap Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$0.29 - $0.72 $115 - $288	-400 Reduced 66.67%	200 $0
Q3 2022 Nov 08, 2022	BUY	$0.92 - $1.75 $92 - $175	100 Added 20.0%	600 $1,000
Q2 2022 Jul 19, 2022	BUY	$0.96 - $1.91 $96 - $191	100 Added 25.0%	500 $1,000
Q1 2022 Apr 29, 2022	SELL	$1.6 - $3.35 $160 - $335	-100 Reduced 20.0%	400 $1,000
Q4 2021 Jan 24, 2022	BUY	$2.08 - $3.65 $416 - $730	200 Added 66.67%	500 $2,000

Q3 2021 Oct 29, 2021	BUY	$1.35 - $4.01 $405 - $1,203	300 New	300 $1,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $198M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.